Leveraging Highly Sensitive NGS FLT3-ITD and NPM1 MRD Assessments in AML← ALL VIDEOSLeveraging Highly Sensitive NGS FLT3-ITD and NPM1 MRD Assessments in AMLDecember 07, 2024PRESENTED BY Nitin Agarwal and Kristen Floyd from MD Anderson Cancer Center Invivoscribe Marketing2024-12-18T09:49:08-08:00